Pub date: 13 Mar 2012 Latin America / Argentina Pharmaceuticals & Healthcare Industry Report
BMI View: Measured in local currency and in US dollars, the value of Argentina's pharmaceutical market is expected to grow at double-digit rates over the five years to 2016, in large part due to inf... Read More
Pub date: 22 Mar 2012 Latin America / Brazil Pharmaceuticals & Healthcare Industry Report
BMI View: Brazil remains the most attractive emerging pharmaceutical market in the Americas due to its large population, strong consumer demand, increasing urbanisation and comparatively good drug r... Read More
Pub date: 29 Sep 2008 Global / Middle East Pharmaceuticals & Healthcare Special Report
Key insights from BMI’s Burden of Disease Database, an online tool that forecasts the burden of 123 diseases in 192 countries through to 2030.... Read More
Pub date: 18 May 2012 Global / Latin America Pharmaceuticals & Healthcare Industry Report
BMI View: As countries are expected to invest heavily in healthcare provision over the medium term, we forecast the pharmaceutical markets of the seven states that comprise Central America to represe... Read More
Pub date: 05 Apr 2012 Latin America / Chile Pharmaceuticals & Healthcare Industry Report
BMI View: Chile's pharmaceutical market is expected to become an increasingly attractive proposition for multinational companies as regulatory and intellectual property (IP) environment improves and ... Read More
Pub date: 02 Mar 2012 Latin America / Colombia Pharmaceuticals & Healthcare Industry Report
BMI View: Colombia's pharmaceutical and healthcare markets will perform better than the regional average over the medium term due to its high urbanisation rate and population growth. Strong macroeco... Read More
Pub date: 27 Feb 2012 Global Pharmaceuticals & Healthcare Special Report
There has been strong appetite from private equity to acquire contract research organisations (CROs) throughout 2011. The spate of acquisitions comes at a time when the industry is undergoing a c... Read More
Pub date: 24 May 2010 Global / Middle East Pharmaceuticals & Healthcare Special Report
In this report, BMI provides an analysis of the implications of the Eurozone sovereign debt crisis on the PIIGS pharmaceutical industries, with a particular focus on the impact of the austerity measur... Read More
Pub date: 16 Sep 2009 Global / North America Pharmaceuticals & Healthcare Special Report
In this special report, BMI assess the impact of the economic downturn on drug expenditure levels in markets across the globe.... Read More
Pub date: 18 May 2012 Latin America / Mexico Pharmaceuticals & Healthcare Industry Report
BMI View: Theoretically, Mexico offers one of the most favourable intellectual property (IP) environments in Latin America, which will continue to prop up multinational interest in the country’s pha... Read More
Pub date: 08 Jun 2011 Global Pharmaceuticals & Healthcare Special Report
This Special Report from Business Monitor International (BMI) examines the global supply of Molybdenum- 99, looking at the likelihood of price rises and the implications of investment. The report i... Read More
Pub date: 01 Jan 2012 Global / Latin America Pharmaceuticals & Healthcare Multinational Companies Industry Directory
Multinational Pharmaceuticals Companies in Latin America CD-ROM... Read More
Pub date: 16 Mar 2012 Latin America / Peru Pharmaceuticals & Healthcare Industry Report
BMI View: Peru's large and growing population underpins the potential of its pharmaceutical market, especially given the rising prevalence of non-communicable diseases. However, Peru remains listed o... Read More
Pub date: 19 Apr 2010 Global Pharmaceuticals & Healthcare Special Report
BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.... Read More
Pub date: 14 Feb 2012 Global Pharmaceuticals & Healthcare Special Report
This Special Report from Business Monitor International (BMI) examines the African healthcare and pharmaceutical markets, looking at the opportunities and characteristics primarily of the sub-Sahar... Read More
Pub date: 25 Jan 2011 Global / North America Pharmaceuticals & Healthcare Special Report
BMI’s analysis of regulatory approvals in 2010 says much about which drugmakers will outperform rivals throughout 2011, with biological blockbuster drugs leading the way.... Read More
Pub date: 12 Apr 2012 Latin America / Venezuela Pharmaceuticals & Healthcare Industry Report
BMI View: Venezuela's pharmaceutical industry will face increasingly harsh pricing policy which is unlikely to tackle the persistent medicine shortage problem. President Hugo Chávez's renewed attempt... Read More